Monitoring fluoropyrimidine metabolism in solid tumors with in vivo 19F magnetic resonance spectroscopy
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 56 (3) , 321-343
- https://doi.org/10.1016/j.critrevonc.2005.03.009
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Increased tumour extracellular pH induced by Bafilomycin A1 inhibits tumour growth and mitosis in vivo and alters 5-fluorouracil pharmacokineticsEuropean Journal Of Cancer, 2003
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerNew England Journal of Medicine, 1999
- 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracilCancer, 1998
- Assessment of the biodistribution and metabolism of 5-fluorouracil as monitored by 18F PET and 19F MRI: A comparative animal studyNuclear Medicine and Biology, 1996
- In vivo 19F NMR Comparative Study of 5-Fluorouracil, 1-(2-Tetrahydrofuryl)-5-fluorouracil (FT) and an FT-Uracil Coadministration System in Mouse Tumors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1994
- Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancerEuropean Journal Of Cancer, 1993
- Metabolism of Tegafur in Rat Liver Observed by in vivo19F Magnetic Resonance Spectroscopy and ChromatographyJapanese Journal of Cancer Research, 1992
- Quantitative P‐31 MR spectroscopy of the liver in alcoholic cirrhosisJournal of Magnetic Resonance Imaging, 1992
- Elucidation of pathways of 5-fluorouracil metabolism in xenografts of human colorectal adenocarcinomaEuropean Journal of Cancer and Clinical Oncology, 1983
- Fluorinated Pyrimidines, A New Class of Tumour-Inhibitory CompoundsNature, 1957